サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565025

血液透析の世界市場

Hemodialysis

出版日
ページ情報
英文 199 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血液透析の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血液透析の世界市場は2030年までに1,306億米ドルに到達

2023年に951億米ドルと推定された血液透析の世界市場は、2023年から2030年にかけてCAGR 4.6%で成長し、2030年には1,306億米ドルに達すると予測されます。血液透析レポートで分析したセグメントの1つである血液透析サービスは、CAGR 4.8％を記録し、分析期間終了までに801億米ドルに達すると予測されます。血液透析医薬品セグメントの成長率は、分析期間中CAGR 3.9％と推定されます。

米国市場は推定251億米ドル、中国はCAGR 7.2％で成長すると予測

米国の血液透析市場は2023年に251億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR7.2％を引きずる形で、2030年までに287億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.8%と3.8%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の血液透析市場- 主要動向と促進要因のまとめ

血液透析は慢性腎臓病患者のライフラインか？

血液透析は、腎不全や慢性腎臓病（CKD）患者の命を救う治療薬ですが、何がそれほどまでに血液透析を必要不可欠なものにしているのでしょうか？血液透析は、腎臓がその機能を果たせなくなった場合に、血液から老廃物、塩分、余分な水分をろ過する医療プロセスです。血液透析は、腎臓の機能を人工的に代替する役割を果たし、患者が水分と電解質のバランスを維持し、毒素を除去し、血圧を管理するのを助けます。血液透析がなければ、末期腎臓病の患者は血流に毒素が蓄積し、生命を脅かす合併症に直面することになります。

この治療はCKD患者にとって特に重要であり、腎移植を待つ間、あるいは移植を受ける資格がない患者の長期管理として、生存のための重要な手段を提供するものです。血液透析では通常、透析の種類に応じて、透析センターまたは自宅で週に何度も治療を受ける必要があります。1回の透析時間は数時間で、血液は透析装置でろ過されてから体内に戻されます。腎臓病の罹患率は世界的に上昇を続けており、特に糖尿病と高血圧の罹患率が増加しているため、血液透析の需要は高まっており、現代医療の重要な一部となっています。

テクノロジーは血液透析治療をどのように向上させたか？

医療技術の進歩により、血液透析の有効性、快適性、利用しやすさが大幅に改善され、難易度の高い治療から、より管理しやすく患者にやさしい治療へと変貌を遂げました。最も注目すべき技術革新のひとつに、患者さんが自宅で快適に透析を行うことができる在宅透析装置（HHD）の開発があります。このポータブルでコンパクトな装置により、透析回数を増やすことができ、スケジュールを柔軟に変更できるため、健康状態の改善と生活の質の向上につながります。在宅血液透析は、患者さんが週に何度も透析センターへ通う必要性を減らし、日常生活に支障をきたさない治療を可能にします。

また、透析装置の技術的な向上により、透析プロセスがより効率的になり、身体への負担も軽減されました。最新の透析装置には、より優れたセンサー、高度なソフトウェア、血流、ろ過速度、体液バランスをリアルタイムで綿密にモニターする自動化システムが搭載されています。このような技術革新により、各透析セッションが患者固有のニーズに合わせて最適化され、低血圧や体液過多などの合併症を減らすことができます。さらに、合成ポリマー製の透析膜など、生体適合性の高い透析膜の開発により、透析装置のろ過機能が向上するとともに、炎症や凝固が最小限に抑えられ、治療がより安全で効果的になりました。

もうひとつの重要な進歩は、ウェアラブル技術や遠隔医療をケアに取り入れたことです。遠隔モニタリングシステムにより、ヘルスケアプロバイダーは、透析が自宅で行われている場合でも、患者のバイタルや治療データをリアルタイムで追跡できるようになった。この接続性により、感染症やアクセス部位の問題などの潜在的な問題を早期に発見し、タイムリーな介入を可能にすることで、入院を減らし、患者の転帰を改善することができます。さらに、より耐久性が高く侵襲性の低い動静脈瘻の開発など、バスキュラーアクセスデバイスの進歩により、アクセス部位の寿命が延び、合併症が減少し、繰り返し手術を受ける必要性が減少しています。このような技術の向上により、血液透析は世界中の患者さんにとって、より効率的で、より安全で、より利用しやすいものとなっています。

なぜ血液透析が腎不全患者に必要なのか？

血液透析が腎不全患者にとって必要不可欠なのは、腎臓がこれらの重要な機能を果たせなくなった場合に、体内の老廃物や余分な水分を除去するための唯一の効果的な治療法だからです。腎臓が機能しなくなると、血液中に毒素、過剰なカリウム、体液が蓄積され、心血管系の問題、肺への体液貯留、危険な電解質不均衡などの深刻な合併症を引き起こす可能性があります。透析がなければ、このような状態は急速に臓器不全を引き起こし、死に至るでしょう。血液透析は、健康な腎臓の濾過プロセスを模倣することで、これらのリスクを管理し、患者が通常の身体機能を維持できるようにします。

生命維持の役割に加えて、血液透析は患者に比較的活動的な生活を送る能力を提供します。体内の老廃物や水分レベルをコントロールすることで、この治療は、進行した腎臓病患者によく見られる疲労、むくみ、息切れなどの症状を軽減します。透析は腎不全を完治させるものではありませんが、QOL（生活の質）を大幅に改善し、患者さんが長期にわたって病状を管理できるようにします。多くの患者さんにとって、血液透析は腎移植への架け橋であり、移植の候補にならない患者さんにとっては、生涯の治療となります。

血液透析は、貧血や骨疾患など腎不全に関連する他の健康合併症の管理にも重要な役割を果たしています。透析中は、これらの症状を改善するための薬剤を投与することが多く、腎不全の複雑な症状を管理するための包括的な治療法となっています。末期腎不全（ESRD）を患う人々にとって、血液透析は単なる治療ではなく、健康を維持し、致命的な合併症の進行を防ぐために必要なものです。腎臓病の有病率は世界的に増加しており、特に糖尿病や高血圧の有病率が高い人々の間では、血液透析は何百万人もの人々にとって重要な治療オプションであり続けています。

血液透析市場の成長を促進する要因は？

血液透析市場の成長は、慢性腎臓病（CKD）の罹患率の上昇、透析装置の技術進歩、世界人口の高齢化など、いくつかの重要な要因によって牽引されています。特に、腎臓病の主要な原因である糖尿病や高血圧などの疾患が世界的に増加し続けているため、CKDの有病率が増加していることが最も大きな要因の1つです。腎臓病の世界の負担増に伴い、血液透析を含む透析サービスの需要は急速に拡大しています。肥満、メタボリックシンドローム、心血管疾患の罹患率が高い地域では、利用しやすい透析治療の必要性が高まっています。

また、透析装置や治療方法の技術的進歩も市場の成長に寄与しています。家庭用透析装置（HHD）、より効率的な透析膜、改善されたバスキュラーアクセス装置などの技術革新により、治療がより患者にやさしく、利用しやすくなっています。特に在宅透析は、従来の施設内透析に比べ、柔軟性があり、健康状態が改善され、生活の質が向上するという利点が、より多くの患者やヘルスケアプロバイダーに認識されるようになり、普及が進んでいます。ポータブル透析装置やウェアラブル・モニタリング技術の利用可能性が高まっていることも、先進国市場、新興国市場の両方において、血液透析の採用に拍車をかけています。

高齢化も血液透析市場の成長を促進する大きな要因です。世界人口の高齢化に伴い、特に60歳以上の腎臓病の発生率が増加しています。高齢者は、加齢に伴う腎機能の低下や、糖尿病や高血圧などの併存疾患の有病率が高いため、CKDを発症する可能性が高くなります。このような人口動向により、長期的な腎臓治療を必要とする患者の増加に対応するための血液透析サービスとインフラに対する需要が高まっています。

最後に、新興市場におけるヘルスケアインフラの改善と透析センターの拡大が、血液透析市場の成長に寄与しています。政府および民間ヘルスケアプロバイダーは、特にこれまで腎臓治療へのアクセスが限られていた地域において、治療需要の増加に対応するために透析サービスの拡大に投資しています。 この拡大により、地方や十分なサービスが受けられていない地域での透析へのアクセスが改善され、市場の成長を促進し、より多くの患者が命を救う血液透析治療を受けられるようになります。世界中のヘルスケアシステムが進化し続ける中、効果的で利用しやすい血液透析ソリューションの需要は拡大し、腎臓病管理の重要な要素としての役割が確固たるものになると予想されます。

調査対象企業の例（全52件）

  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Baxter International, Inc.
  • DaVita Healthcare Partners, Inc.
  • Fresenius Medical Care AG & Co. KgaA
  • Kawasumi Laboratories, Inc.
  • Medical Components, Inc.
  • Merit Medical Systems, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Teleflex, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12339

Global Hemodialysis Market to Reach US$130.6 Billion by 2030

The global market for Hemodialysis estimated at US$95.1 Billion in the year 2023, is expected to reach US$130.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Hemodialysis Services, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$80.1 Billion by the end of the analysis period. Growth in the Hemodialysis Drugs segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.1 Billion While China is Forecast to Grow at 7.2% CAGR

The Hemodialysis market in the U.S. is estimated at US$25.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$28.7 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Hemodialysis Market - Key Trends and Drivers Summarized

Is Hemodialysis the Lifeline for Patients with Chronic Kidney Disease?

Hemodialysis is a life-saving treatment for individuals with kidney failure or chronic kidney disease (CKD), but what makes it so essential? Hemodialysis is a medical process that filters waste, salts, and excess fluids from the blood when the kidneys can no longer perform this function. It acts as an artificial replacement for kidney function, helping patients maintain a balance of fluids and electrolytes, remove toxins, and manage blood pressure. Without hemodialysis, individuals with end-stage kidney disease would face life-threatening complications from toxin buildup in their bloodstream.

This treatment is particularly important for patients with CKD, as it provides a critical means of survival while they await a kidney transplant or as long-term management for those who are not eligible for transplantation. Hemodialysis typically requires patients to undergo treatments multiple times a week, either in a dialysis center or at home, depending on the type of dialysis prescribed. Each session can last several hours, during which blood is filtered through a dialysis machine before being returned to the body. As the incidence of kidney disease continues to rise globally, particularly with increasing rates of diabetes and hypertension, the demand for hemodialysis has grown, making it a crucial part of modern healthcare.

How Has Technology Enhanced Hemodialysis Treatment?

Advancements in medical technology have significantly improved the effectiveness, comfort, and accessibility of hemodialysis, transforming it from a challenging procedure to a more manageable and patient-friendly treatment. One of the most notable innovations is the development of home hemodialysis (HHD) machines, which allow patients to perform dialysis in the comfort of their own homes. These portable, compact devices enable more frequent dialysis sessions with greater flexibility in scheduling, leading to better health outcomes and improved quality of life. Home hemodialysis reduces the need for patients to travel to dialysis centers multiple times a week, making the treatment less disruptive to daily life.

Technological improvements in dialysis machines have also made the process more efficient and less taxing on the body. Modern machines feature better sensors, advanced software, and automated systems that closely monitor blood flow, filtration rates, and fluid balance in real time. These innovations ensure that each dialysis session is optimized for the patient’s specific needs, reducing complications such as hypotension or fluid overload. Furthermore, developments in biocompatible dialysis membranes—such as those made from synthetic polymers—have enhanced the filtering capabilities of dialysis machines while minimizing inflammation and clotting, making treatments safer and more effective.

Another key advancement is the integration of wearable technologies and telemedicine into hemodialysis care. Remote monitoring systems now allow healthcare providers to track a patient’s vitals and treatment data in real-time, even when dialysis is performed at home. This connectivity enables early detection of potential issues, such as infections or access site problems, and allows for timely interventions, reducing hospital admissions and improving patient outcomes. In addition, advancements in vascular access devices, such as the creation of more durable and less invasive arteriovenous (AV) fistulas, have extended the lifespan of access sites, reducing complications and the need for repeated surgeries. These technological enhancements are making hemodialysis more efficient, safer, and accessible for patients worldwide.

Why Is Hemodialysis Essential for Patients with Kidney Failure?

Hemodialysis is essential for patients with kidney failure because it serves as the only effective treatment option for removing waste products and excess fluid from the body when the kidneys can no longer perform these vital functions. In the absence of functioning kidneys, the buildup of toxins, excess potassium, and fluids in the bloodstream can lead to severe complications, including cardiovascular issues, fluid retention in the lungs, and dangerous electrolyte imbalances. Without dialysis, these conditions would rapidly lead to organ failure and death. Hemodialysis helps manage these risks by mimicking the filtration process of healthy kidneys, allowing patients to maintain a semblance of normal bodily function.

In addition to its life-sustaining role, hemodialysis offers patients the ability to lead relatively active lives. By controlling waste and fluid levels in the body, the treatment reduces symptoms like fatigue, swelling, and shortness of breath, which are common in patients with advanced kidney disease. While dialysis does not cure kidney failure, it significantly improves quality of life and enables patients to manage their condition over the long term. For many, hemodialysis is a bridge to kidney transplantation, while for others who are not candidates for transplant, it becomes a lifelong treatment.

Hemodialysis also plays a vital role in managing other health complications related to kidney failure, such as anemia and bone disease. During dialysis sessions, patients often receive medications that help regulate these conditions, making the treatment a comprehensive approach to managing the complexities of kidney failure. For those who suffer from end-stage renal disease (ESRD), hemodialysis is not only a treatment but a necessity for maintaining health and preventing the progression of potentially fatal complications. As the prevalence of kidney disease increases globally, particularly in populations with high rates of diabetes and hypertension, hemodialysis remains a critical treatment option for millions of people.

What Factors Are Driving the Growth of the Hemodialysis Market?

The growth of the hemodialysis market is driven by several key factors, including the rising incidence of chronic kidney disease (CKD), technological advancements in dialysis equipment, and an aging global population. One of the most significant drivers is the increasing prevalence of CKD, particularly as conditions like diabetes and hypertension—two leading causes of kidney disease—continue to rise worldwide. With the global burden of kidney disease growing, the demand for dialysis services, including hemodialysis, is expanding rapidly. In regions with high rates of obesity, metabolic syndrome, and cardiovascular disease, the need for accessible dialysis treatments is becoming more urgent.

Technological advancements in dialysis machines and treatment methods are also contributing to market growth. Innovations such as home hemodialysis (HHD) machines, more efficient dialysis membranes, and improved vascular access devices are making treatments more patient-friendly and accessible. Home hemodialysis, in particular, is gaining traction as more patients and healthcare providers recognize the benefits of flexibility, improved health outcomes, and better quality of life compared to traditional in-center dialysis. The increasing availability of portable dialysis devices and wearable monitoring technologies is further fueling the adoption of hemodialysis in both developed and developing markets.

An aging population is another major factor driving the growth of the hemodialysis market. As the global population ages, the incidence of kidney disease increases, particularly among individuals over the age of 60. Older adults are more likely to develop CKD due to age-related declines in kidney function and the higher prevalence of comorbidities such as diabetes and hypertension. This demographic trend is increasing the demand for hemodialysis services and infrastructure to accommodate the growing number of patients requiring long-term kidney care.

Lastly, improved healthcare infrastructure and the expansion of dialysis centers in emerging markets are contributing to the growth of the hemodialysis market. Governments and private healthcare providers are investing in the expansion of dialysis services to meet the rising demand for treatment, particularly in regions where access to kidney care has historically been limited. This expansion is improving access to dialysis in rural and underserved areas, driving market growth and ensuring that more patients can receive life-saving hemodialysis treatments. As healthcare systems around the world continue to evolve, the demand for effective, accessible hemodialysis solutions is expected to grow, solidifying its role as a critical component of kidney disease management.

Select Competitors (Total 52 Featured) -

  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Baxter International, Inc.
  • DaVita Healthcare Partners, Inc.
  • Fresenius Medical Care AG & Co. KgaA
  • Kawasumi Laboratories, Inc.
  • Medical Components, Inc.
  • Merit Medical Systems, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Teleflex, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Hemodialysis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Kidney Disease (CKD) Propels Demand for Hemodialysis
    • Growth in Aging Population Expands Addressable Market for Hemodialysis Services
    • Technological Advancements in Hemodialysis Machines Spur Innovation and Adoption
    • Increasing Focus on Home-based Hemodialysis Expands Market Opportunities
    • Expansion of Dialysis Centers in Emerging Markets Strengthens Business Case for Hemodialysis
    • Growth in Demand for Portable Hemodialysis Devices Sets the Stage for Market Expansion
    • Role of Hemodialysis in Supporting Long-term Management of End-stage Renal Disease (ESRD)
    • Increasing Adoption of Wearable Dialysis Devices Expands Market Potential
    • Role of Artificial Intelligence in Enhancing Hemodialysis Efficiency and Outcomes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemodialysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumables & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumables & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Consumables & Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dialysis Centers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dialysis Centers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Dialysis Centers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • CHINA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hemodialysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hemodialysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • INDIA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hemodialysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hemodialysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hemodialysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Hemodialysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hemodialysis by Segment - Services, Drugs and Consumables & Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Hemodialysis by Segment - Percentage Breakdown of Value Sales for Services, Drugs and Consumables & Equipment for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hemodialysis by End-Use - Dialysis Centers & Hospitals and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Hemodialysis by End-Use - Percentage Breakdown of Value Sales for Dialysis Centers & Hospitals and Home Care for the Years 2014, 2024 & 2030

IV. COMPETITION